No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ETON241220C2500
- 0.00
- 0.000.00%
15min DelayClose Dec 20 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-80.11%PremiumDec 20, 2024Expiry Date10.07Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.21Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Craig-Hallum Initiates Eton Pharmaceutical(ETON.US) With Buy Rating
Eton Pharmaceuticals Closes Acquisition of Increlex (Mecasermin Injection)
Eton Pharmaceuticals Closes Acquisition Of Increlex(R) (Mecasermin Injection) >ETON
Express News | Eton Pharmaceuticals Closes Acquisition of Increlex® (Mecasermin Injection)
Eton Pharmaceuticals Announced The Full Readout From The Clinical Trial Evaluating PKU GOLIKE As A Protein Substitute For Phenylketonuria In Patients During Prolonged Fasting Periods
Express News | Eton Pharmaceuticals Announces Final Readout of Pku Golike® Clinical Trial